Suicide? Or Bush mopping up a little unfinished business before he enters the private sector?

Iraq? By the time those nukes were diverted Iraq was not the target. Heck, the  Iraq war at a dull roar is great for business. The Oil flow there is up as an insurgent action is hardly an inpediment and a little war does wonders for pushing up the price despite ever increasing supply. The Maliki puppet regime  continues to break up the Iraqi national oil company and give it away to US oil interests.

No those nukes were destined for Iran.

Last edited by Johnny_Rotten (2008-08-01 16:08:23)

Johnny_Rotten wrote:

Iraq? By the time those nukes were diverted Iraq was not the target. Heck, the  Iraq war at a dull roar is great for business. The Oil flow there is up as an insurgent action is hardly an inpediment and a little war does wonders for pushing up the price despite ever increasing supply. The Maliki puppet regime  continues to break up the Iraqi national oil company and give it away to US oil interests.

No those nukes were destined for Iran.

I meant to say Iran.  I had several things going on at once and didn’t do a good job of proofreading before posting.

Divert Nuc's?  Why would we need to do that?  Such a silly lot you are . . .

The CIA has all the nuc's they need to start the Holy War, a couple of aging SRAM's really wouldn't play any feasible part.

Well what do you know. My jest about making sure you hire the people with the connections to Cheney turns out to be correct.

It looks like Ivins and his corporate overlords really screwed the pooch on this one. Turns out it was his competitors who managed to pay the required amount of silver to Cheney's people.  Thereby guarantying that the government shitcans Ivin's new vaccine and refuse to pay up for his partner company VaxGen Inc. to develop it.

Just reading about the whole frickin affair and the billions being made off it just makes me feel dirty.

Yet nearly six years later, the old vaccine is still the only one available -- and the government is buying it in mass quantities for the Strategic National Stockpile.

The manufacturer, Emergent BioSolutions Inc. of Rockville, Md., prevailed in a bitter struggle with a rival company that was preparing what federal health officials expected to be a superior vaccine. The episode illustrates the clout wielded by well-connected lobbyists over billions in spending for the Bush administration's anti-terrorism program.

Emergent's rival, VaxGen Inc. of South San Francisco, had spent four years developing a new anthrax vaccine and had won an $877.5-million federal contract to deliver enough doses for 25 million people. The contract threatened Emergent's very existence. The old vaccine, its only moneymaker, would likely be obsolete if VaxGen succeeded.

Emergent responded by mobilizing more than 50 lobbyists, including former aides to Vice President Dick Cheney, to make the case that relying on the new vaccine was a gamble and that the nation's safety depended on buying more of Emergent's product.